Blend Labs (NYSE:BLND) Price Target Lowered to $2.00 at UBS Group

Blend Labs (NYSE:BLNDFree Report) had its price objective decreased by UBS Group from $3.00 to $2.00 in a report published on Wednesday,Benzinga reports. UBS Group currently has a neutral rating on the stock.

Several other equities analysts have also recently issued reports on the company. Citizens Jmp decreased their price target on Blend Labs from $7.00 to $5.00 and set a “market outperform” rating on the stock in a report on Wednesday. Wells Fargo & Company cut their target price on shares of Blend Labs from $5.00 to $4.00 and set an “overweight” rating on the stock in a research report on Wednesday. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Blend Labs in a research note on Wednesday, January 21st. Finally, Wall Street Zen upgraded shares of Blend Labs from a “sell” rating to a “hold” rating in a research report on Sunday, November 16th. Four investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $4.13.

View Our Latest Stock Report on BLND

Blend Labs Stock Performance

NYSE:BLND opened at $1.81 on Wednesday. The stock’s fifty day moving average price is $2.30 and its two-hundred day moving average price is $3.01. Blend Labs has a 52-week low of $1.57 and a 52-week high of $4.49. The company has a market cap of $468.84 million, a price-to-earnings ratio of -18.05 and a beta of 1.27.

Blend Labs (NYSE:BLNDGet Free Report) last released its earnings results on Tuesday, March 10th. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.01 by ($0.04). The firm had revenue of $32.37 million during the quarter, compared to the consensus estimate of $31.78 million. On average, equities analysts predict that Blend Labs will post -0.19 EPS for the current fiscal year.

Insider Buying and Selling

In other Blend Labs news, insider Brian Kneafsey sold 25,000 shares of the stock in a transaction dated Thursday, January 15th. The stock was sold at an average price of $3.06, for a total value of $76,500.00. Following the transaction, the insider owned 649,824 shares of the company’s stock, valued at approximately $1,988,461.44. This represents a 3.70% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders sold a total of 33,125 shares of company stock valued at $93,169 in the last ninety days. Corporate insiders own 35.52% of the company’s stock.

Institutional Trading of Blend Labs

Institutional investors and hedge funds have recently modified their holdings of the stock. Caitong International Asset Management Co. Ltd raised its position in shares of Blend Labs by 248.8% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 30,645 shares of the company’s stock valued at $93,000 after acquiring an additional 21,859 shares during the period. Virtu Financial LLC grew its holdings in Blend Labs by 356.6% during the fourth quarter. Virtu Financial LLC now owns 63,823 shares of the company’s stock valued at $194,000 after purchasing an additional 49,845 shares during the period. Invesco Ltd. increased its stake in Blend Labs by 16.5% in the fourth quarter. Invesco Ltd. now owns 342,236 shares of the company’s stock valued at $1,040,000 after purchasing an additional 48,530 shares in the last quarter. Lexington Hill Partners LLC bought a new stake in Blend Labs in the fourth quarter valued at approximately $42,000. Finally, EP Wealth Advisors LLC acquired a new stake in Blend Labs in the fourth quarter worth $695,000. 52.56% of the stock is owned by institutional investors.

Trending Headlines about Blend Labs

Here are the key news stories impacting Blend Labs this week:

  • Positive Sentiment: Company announced a $50 million share buyback, which supports the stock by reducing float and signaling management confidence. Blend Labs stock climbs after $50M stock buyback
  • Positive Sentiment: Wells Fargo lowered its price target (to $4) but maintained an “overweight” stance, implying the firm still sees material upside versus current levels. Wells Fargo price target update
  • Positive Sentiment: Citizens JMP trimmed its target but kept a “market outperform” rating (PT lowered to $5), another vote of confidence that the stock can rebound longer term. Citizens JMP price target change
  • Neutral Sentiment: Q4 revenue of $32.37M modestly beat consensus ($31.78M), showing top-line momentum but not a large beat. Blend Labs press release
  • Neutral Sentiment: CEO emphasized long-term confidence on the call, a reassuring tone for investors but not an immediate financial catalyst. CEO: “I have never been more excited”
  • Negative Sentiment: Blend reported an EPS miss (loss of $0.03 vs. $0.01 expected), which pressured near-term valuation and raises questions about margin recovery. Blend Labs Q4 earnings summary
  • Negative Sentiment: Q1 revenue guidance of $28.5M–$30.0M came in below the Street (~$31.9M), which is the main driver of caution and likely why some analysts trimmed forecasts. Preliminary Q4 and guidance
  • Negative Sentiment: Analysts have cut forecasts after the Q4/guide print, and UBS lowered its target to $2 with a “neutral” rating—reducing expected upside from some corners of the market. Analysts slash forecasts after Q4 results

Blend Labs Company Profile

(Get Free Report)

Blend Labs, Inc operates as a financial technology company that offers a digital consumer banking platform designed to simplify and automate the lending and account opening processes for banks and credit unions. Its cloud-native software enables financial institutions to deliver a more seamless customer experience by consolidating multiple steps—such as application intake, identity verification, document collection and underwriting—into a unified digital workflow. Blend’s platform is built to integrate with existing core banking systems and third-party data providers, allowing clients to accelerate loan origination and deposit account opening while maintaining compliance and security standards.

The company’s product suite includes solutions for mortgage origination, home equity lending, consumer personal lending and deposit account opening.

Recommended Stories

Analyst Recommendations for Blend Labs (NYSE:BLND)

Receive News & Ratings for Blend Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blend Labs and related companies with MarketBeat.com's FREE daily email newsletter.